Shares of Jubilant Ingrevia Ltd surged 4.52% to ₹712.80 on Friday morning following a large block deal involving 98.65 lakh shares. The deal, valued at ₹666.88 crore, saw shares exchanged at ₹676 apiece — slightly below the previous close of ₹682.
This transaction is part of the Bhartia family’s broader stake sale across its group companies, including Jubilant FoodWorks and Jubilant Pharmova, as reported by CNBC-TV18. Morgan Stanley acted as the broker for the block deals.
Jubilant Ingrevia Block Deal: 98.65 lakh shares worth Rs 666.88 crore change hands
Jubilant Ingrevia, a key player in life sciences ingredients and specialty chemicals, has been expanding its global reach and innovation pipeline. Despite the discount pricing, strong investor demand for the stock pushed it nearly 5% higher, making it one of the top gainers on the NSE today.
The company’s market cap stood at ₹112.80 billion, with shares touching an intraday high of ₹724.